Evaluation of occlusal force following rapid maxillary expansion assisted by piezocision in adolescent versus young adult orthodontic patients: a prospective clinical study.
NCT ID NCT07810465
First seen Sep 09, 2026 · Last updated Sep 09, 2026
Summary
The aim of this prospective clinical study is to evaluate and compare the changes in occlusal force distribution using a quantitative digital occlusal analysis system following piezocision-assisted rapid maxillary expansion (RME) in adolescent versus young adult orthodontic patients. The study hypothesis is that piezocision-assisted RME will result in significant changes in occlusal force distribution and that these outcomes may differ between age groups over a 3-month follow-up period.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 16 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
14 to 22 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1 - Patients with transverse maxillary deficiency. 2. Age range 14-22 years 3. Permanent dentition stage. 4. Good general and oral health. Exclusion Criteria: 1. Craniofacial anomalies or syndromes. 2. History of orthognathic surgery. 3. Periodontal disease or significant bone loss. 4. Systemic diseases affecting bone metabolism. 5. Previous orthodontic treatment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Maxillary transverse deficiency are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Department of Orthodontics, Faculty of Dental Medicine, Al-Azhar University
Cairo, Naser City, 11751, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital vs. direct: which method places jaw screws more accurately?
- Braces-Free jaw widening: new study tests clear aligners in kids
- Dental showdown: which brace works best for Kids' crossbite?
- 3D-Printed expander vs. traditional device: which works better for kids?
- Narrow jaw study uses 3D scans to see how expansion changes face and sinus
- Which expander hurts less? new study for kids with crossbite